Reaction
Reflux Oesophagitis reporting signals
As of the last recalculation, Reflux Oesophagitis appears in 759 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is RIZATRIPTAN BENZOATE (PRR 30.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rizatriptan Benzoate | 11 | 30.1 | 30.1 |
| Gefitinib | 5 | 15.3 | 15.3 |
| Metformin Hcl | 28 | 14.4 | 14.4 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 7 | 8.2 | 8.2 |